Evidence map›Paper›PMID 33716283›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Granulomatous-lymphocytic Interstitial Lung Disease Associated with Good's Syndrome That Responded to Immunoglobulin Therapy.

Kyoko Gocho, Tokuhiro Kimura, Shinya Matsushita, Saeko Shinozawa, Nobuyuki Hamanaka, Yoshimasa Inoue, Tamiko Takemura

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kyoko GochoDepartment of Respiratory Medicine, Saiseikai Yokohamashi Tobu Hospital, Japan.
Tokuhiro KimuraDepartment of Diagnostic Pathology, Saiseikai Yokohamashi Tobu Hospital, Japan.
Shinya MatsushitaDepartment of Respiratory Medicine, Saiseikai Yokohamashi Tobu Hospital, Japan.
Saeko ShinozawaDepartment of Respiratory Medicine, Saiseikai Yokohamashi Tobu Hospital, Japan.
Nobuyuki HamanakaDepartment of Respiratory Medicine, Saiseikai Yokohamashi Tobu Hospital, Japan.
Yoshimasa InoueDivision of Respiratory Surgery, Saiseikai Yokohamashi Tobu Hospital, Japan.
Tamiko TakemuraDepartment of Pathology, Kanagawa Cardiovascular and Respiratory Center, Japan.
Kanagawa Cardiovascular and Respiratory Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Good's syndrome is associated with thymoma and acquired immunodeficiency. A 54-year-old man visited our hospital with a complaint of cough. Chest imaging revealed diffuse nodular shadows and anterior mediastinal mass. Hypogammaglobulinemia and a decreased B lymphocyte count were found by a laboratory evaluation. The lung nodules markedly regressed after immunoglobulin therapy. The mediastinal mass and remaining nodule were surgically resected and diagnosed as a type AB thymoma and a necrotizing epithelioid granuloma with T lymphocyte-dominant alveolitis, respectively. The overall appearances of these lesions were mostly in line with the spectrum of granulomatous-lymphocytic interstitial lung disease associated with Good's syndrome.

Indexed as

AgammaglobulinemiaLung Diseases, InterstitialThymomaThymus NeoplasmsHumansImmunization, PassiveMaleMiddle AgedGood's syndromegranulomatous-lymphocytic interstitial lung diseasehypogammaglobulinemiaimmunoglobulin therapy

Identifiers

PMID33716283
PMCPMC8545647
OpenAlexW3136836151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.